Clinical Trial Update: The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating galantamine's effect on attention and frontal function in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Alzheimer Disease | Phase 4 | Status: COMPLETED